Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 7, 2025
Risk factors for brucellosis relapse and focal complications: A nine-year multicenter study in an endemic region
Maryam Dadar, Niloofar Sadooghi, Fereshteh Ansari, et al.
The Journal of Infectious Diseases
|
July 23, 2002
Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis
Guillermo H Giambartolomei, M Victoria Delpino, Mariela E Cahanovich, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
March 31, 2019
Ultrasound and Histopathologic Correlation of Ovarian Cystadenofibromas: Diagnostic Value of the "Shadow Sign"
Ilan E Timor-Tritsch, Esther Yoon, Ana Monteagudo, et al.
Cancer Treatment Reports
|
April 1, 1978
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy
H W Bruckner, C J Cohen, R C Wallach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group
Howard Hochster, Elizabeth R Plimack, Carolyn D Runowicz, et al.
Infection and Immunity
|
November 7, 2007
Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2
Paula Barrionuevo, Juliana Cassataro, M Victoria Delpino, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1986
Endocrine aspects of human uterine sarcoma: a preliminary study
L Tseng, J K Tseng, W J Mann, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1983
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)
C J Cohen, J D Goldberg, J F Holland, et al.
Cancer
|
May 1, 1981
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin
H W Bruckner, C J Cohen, J D Goldberg, et al.
American Journal of Obstetrics and Gynecology
|
March 15, 1983
Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer
H W Bruckner, C J Cohen, J D Goldberg, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 7, 2025
Risk factors for brucellosis relapse and focal complications: A nine-year multicenter study in an endemic region
Maryam Dadar, Niloofar Sadooghi, Fereshteh Ansari, et al.
The Journal of Infectious Diseases
|
July 23, 2002
Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis
Guillermo H Giambartolomei, M Victoria Delpino, Mariela E Cahanovich, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
March 31, 2019
Ultrasound and Histopathologic Correlation of Ovarian Cystadenofibromas: Diagnostic Value of the "Shadow Sign"
Ilan E Timor-Tritsch, Esther Yoon, Ana Monteagudo, et al.
Cancer Treatment Reports
|
April 1, 1978
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy
H W Bruckner, C J Cohen, R C Wallach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group
Howard Hochster, Elizabeth R Plimack, Carolyn D Runowicz, et al.
Infection and Immunity
|
November 7, 2007
Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2
Paula Barrionuevo, Juliana Cassataro, M Victoria Delpino, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1986
Endocrine aspects of human uterine sarcoma: a preliminary study
L Tseng, J K Tseng, W J Mann, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1983
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)
C J Cohen, J D Goldberg, J F Holland, et al.
Cancer
|
May 1, 1981
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin
H W Bruckner, C J Cohen, J D Goldberg, et al.
American Journal of Obstetrics and Gynecology
|
March 15, 1983
Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer
H W Bruckner, C J Cohen, J D Goldberg, et al.
Page
of 10